Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sarah Sagorsky
Clinical Benefit to an Aurora a Kinase Inhibitor in a Patient With Metastatic Integrase Interactor 1‐Deficient Carcinoma
Oncologist
Cancer Research
Medicine
Oncology
Related publications
VHL Loss Predicts Response to Aurora Kinase a Inhibitor in Renal Cell Carcinoma Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Aurora Kinase a (AURKA; Aurora-A)
Science-Business eXchange
Clinical Outcome of Third-Line Pazopanib in a Patient With Metastatic Renal Cell Carcinoma
Case Reports in Oncological Medicine
Oncology
Marked Leukemoid Reaction in a Patient With Metastatic Breast Carcinoma
American Journal of Hematology
Hematology
A Phase I Study of BI 811283, an Aurora B Kinase Inhibitor, in Patients With Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Antitumor Activity of MLN8054, an Orally Active Small-Molecule Inhibitor of Aurora a Kinase
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Cyclin-Dependent Kinase Inhibitor-1-Deficient Mice Are Susceptible to Osteoarthritis Associated With Enhanced Inflammation
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
Metastatic Adamantinoma Responds to Treatment With Receptor Tyrosine Kinase Inhibitor
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Targeting Hepatocarcinogenesis Model in C56BL6 Mice With Pan-Aurora Kinase Inhibitor Danusertib
Journal of Cancer
Oncology